Growth Metrics

Integra Lifesciences Holdings (IART) Profit After Tax Growth (3y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -6.51%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 7.96%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -2.39%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 62.16%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 3.79%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 30.83%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 60.12%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 3.38%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 6.53%
10 Integra Lifesciences Holdings 1.20 Bn 939.16 Mn 216.98 Mn -29.87%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -29.87%
Dec 31, 2025 -26.66%
Sep 30, 2025 -28.23%
Jun 30, 2025 -133.97%
Mar 31, 2025 -40.42%
Dec 31, 2024 -24.63%
Sep 30, 2024 -30.99%
Jun 30, 2024 -33.02%
Mar 31, 2024 -27.49%
Dec 31, 2023 -40.20%
Sep 30, 2023 -15.52%
Jun 30, 2023 137.16%
Mar 31, 2023 38.19%
Dec 31, 2022 51.19%
Sep 30, 2022 56.16%
Jun 30, 2022 14.63%
Mar 31, 2022 0.15%
Dec 31, 2021 21.77%
Sep 30, 2021 48.15%
Jun 30, 2021 45.54%
Mar 31, 2021 60.44%
Dec 31, 2020 27.87%
Sep 30, 2020 117.13%
Jun 30, 2020 -26.70%
Mar 31, 2020 12.81%
Dec 31, 2019 -18.45%
Sep 30, 2019 -49.94%
Jun 30, 2019 32.60%
Mar 31, 2019 34.65%
Dec 31, 2018 18.83%
Sep 30, 2018 34.20%
Jun 30, 2018 -1.82%
Mar 31, 2018 9.45%
Dec 31, 2017 29.54%
Sep 30, 2017 -29.43%
Jun 30, 2017 30.95%
Mar 31, 2017 34.67%
Dec 31, 2016 27.06%
Sep 30, 2016 38.63%
Jun 30, 2016 103.21%
Mar 31, 2016 61.68%
Dec 31, 2015 5.42%
Sep 30, 2015 -64.03%
Jun 30, 2015 12.18%
Mar 31, 2015 7.80%
Dec 31, 2014 64.79%
Sep 30, 2014 -7.18%
Jun 30, 2014 90.40%
Mar 31, 2014 -38.92%
Dec 31, 2013 -9.87%
Sep 30, 2013 -56.60%
Jun 30, 2013 -53.54%
Mar 31, 2013 -33.81%
Dec 31, 2012 -6.68%
Sep 30, 2012 -2.90%
Jun 30, 2012 -8.80%